Browsing Tag
BK virus infection
1 post
Memo Therapeutics secures $15.5m in Series B to propel antibody development for COVID-19 and BK virus treatment
Memo Therapeutics, a Swiss biotech company, has successfully raised CHF 14 million (approximately $15.56 million) in a Series…